News

The Nuclear Medicine radiopharmaceutical laboratory (Q-TRacE) at the Royal Brisbane and Women’s Hospital (RBWH) and Herston Imaging Research Facility (HIRF) teams collaborated to ensure the successful launch of the first Australia Dementia Network (ADNeT) patient scanned in Australia on the 7th October 2021.

QTRaCE Team WebImage

Pictured at the RBWH Hot Lab is the QTRaCE Team (Left to Right)
Back: Zena Rainbird (Radiochemist), William Hunt (Radiochemist), Cassandra Fulcher (Radiochemist), Soren Lummis (Senior Radiochemist), Christoph Barkhausen (NIF Radiochemistry Fellow), Dominique Scott (Senior Radiochemist), Nicholas Aslin (Radiochemist)
Front: Shannon Millar (Production Manager), Talia Enright (Radiochemist), Gemma Maguire (Acting Quality Assurance Manager)
Absent: Dr Melissa Latter (Principal Radiochemist), Stephen Tapper (Advanced Radiochemist), Paul Coogan (Acting laboratory Manager)

The HIRF Imaging Team with the first Australia Dementia Network (ADNeT) patient to be scanned in Australia yesterday.

The ADNeT project is a Phase I, multiple site, open label study. The project aims to compare and establish interventions for Alzheimer’s disease (AD) and other neurodegenerative diseases causing dementia.

HIRF would like to extend a warm welcome to our newly appointed Director, Professor Graham Galloway.

Graham has had a long research career, with expertise in both magnetic resonance imaging and molecular or PET imaging. His research projects are characterised by their multidisciplinary background, with Graham uniquely positioned to draw together these apparently disparate threads. He is renown for pushing the boundaries of the technology into new applications. Graham has been pivotal in establishing collaborative research infrastructure across Australia.

HIRF is opening its support scheme for 2021. This year, HIRF is offering in-kind scan time to support the collection of pilot data for larger grants (such as ARC or NHMRC).

Applications due: 5pm, Friday 16th July.

Any queries please get in touch with either Marita Prior (This email address is being protected from spambots. You need JavaScript enabled to view it.) or Katie McMahon (This email address is being protected from spambots. You need JavaScript enabled to view it.).

 

For more information please downlolad the HIRF 2021 scheme guidance and application.

In conjunction with QUT, HIRF ran a short course on the use of MR in guiding radiation therapy on the last Saturday in May. The course was designed by HIRF’s chief radiographer, Clare Berry, and acting Director, Katie McMahon. The one-day course was a hands-on introduction to MR safety, patient screening, the common receiver coils and imaging protocols for oncology patients, as well as MRI artefacts and corrections. The team had a great time with our course participants, and radiation therapy gurus from QUT, Julie Burberry and Peta Rutledge.

 

IMG 1433 small IMG 1432 Small IMG 1435 small

 

HIRF says a fond farewell to Peta Gray as operations manager, and welcomes Marita Prior to the role.

After Easter, Peta will go back to her permanent position within the Nuclear Medicine Department of RBWH. She will still be involved in HIRF on our nuclear medicine scientist roster, so we will still be able to benefit from her PET expertise. Marita Prior comes from the Department of Medical Imaging with a background in imaging research and coordination.

If you have any questions for the HIRF operations manager, please use the This email address is being protected from spambots. You need JavaScript enabled to view it. email.

Queensland University of Technology will introduce the first practical hands-on day of their new MRI for Radiation Therapists course in 2021, to be hosted at HIRF. Spectrum spoke with HIRF Acting Director, Professor Katie McMahon about the development of this important educational program. The article was published in the March edition, available online to ASMIRT members.

There are exciting advances in MR-guided radiation therapy with the first MR-Linac installed in Townsville in 2019. QUT’s radiation therapy gurus, Peta Rutledge and Julie Burbery, developed an online continuing professional eduction program in coordination with HIRF staff, Clare Berry and Katie McMahon, on how to address the MRPBA professional capabilities. To complement the online course, a practical day has been developed which covers MR safety and patient screening, MR positioning, common oncology scan protocols, anatomy and motion and artefact corrections. For more information contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

The PRIMARY trial investigates the additive diagnostic value of the PET PSMA tracer – What’s its ability to reduce unnecessary prostate biopsies in men being investigated for prostate cancer.

We asked lead researcher Dr Matthew Roberts to offer some insight into the project and how HIRF is contributing to clinical innovation.

PET First is a prospective study of up-front PET/CT in guiding diagnostic interventions in investigating pulmonary nodules suspicious for lung cancer. We asked lead researcher David Fielding to offer some insight into the project and how HIRF is contributing to clinical innovation.

Herston Imaging Research Facility (HIRF) is now home to a new 18 channel breast coil for MRI, which delivers brilliant image quality and is better able to visualise masses in dense tissue.
The HIRF team are thrilled to have this new equipment available for clinicians and researchers looking to further examine abnormalities found during mammogram or ultrasound. 

Herston Imaging Research Facility was officialy open by The Honourable Annastacia Palaszczuk, Premier and Minister for the Arts.

GENERAL ENQUIRIES

Telephone:
+61 7 3646 5820

Email:
HIRFAdministration@health.qld.gov.au

ADDRESS

Level 3, UQCCR
Building 71/918
Royal Brisbane and Women's Hospital
Herston QLD 4029 Australia

Copyright © 2021 Herston Imaging Research Facility.

Website design by Marketeam

Main Menu